secwatch.observer — SEC 8-K summary
======================================

Issuer:     Exousia Bio, Inc. (LMMY)
CIK:        0001939937
Form:       8-K
Filed at:   2024-12-17T23:59:59+00:00
Accession:  0001683168-24-008767
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.01, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Zhang Shengwu acquires 64.29% of LAMY, becomes sole director and CEO
--------------------------------------------------------------------

- Zhang Shengwu purchased 5,250,000 shares (64.29% voting control) for $335,910 from Witmer and Townsend.
- Dwight Witmer resigned as Director, CEO, CFO, Secretary; Stephen Townsend resigned as Director, COO.
- Zhang Shengwu appointed as Sole Director, President, CEO, Secretary; will devote at least 20 hours/week.
- Zhang Shengwu is CEO of Shanghai Jiuye Technology Group; former Director of Operations at Dalian Damao Surveying.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1939937/000168316824008767/0001683168-24-008767-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1939937/000168316824008767/lamy_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-008767

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer